Related references
Note: Only part of the references are listed.36O * DETECTION OF EGFR T790M MUTATION IN URINARY CIRCULATING TUMOR DNA FROM METASTATIC NON-SMALL CELL LUNG CANCER PATIENTS
H. Husain et al.
ANNALS OF ONCOLOGY (2015)
COUNTERPOINT: Should Lung Cancer Screening by Chest CT Scan Be a Covered Benefit? No
Katherine Courtright et al.
CHEST (2015)
Ultra-Sensitive Detection of the Pretreatment EGFR T790M Mutation in Non-Small Cell Lung Cancer Patients with an EGFR-Activating Mutation Using Droplet Digital PCR
Masaru Watanabe et al.
CLINICAL CANCER RESEARCH (2015)
AZD9291 in EGFR Inhibitor-Resistant Non-Small-Cell Lung Cancer
Pasi A. Jaenne et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Circulating Tumor DNA Is Effective for the Detection of EGFR Mutation in Non-Small Cell Lung Cancer: A Meta-analysis
Mantang Qiu et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2015)
Prospective Blinded Study of BRAFV600E Mutation Detection in Cell-Free DNA of Patients with Systemic Histiocytic Disorders
David M. Hyman et al.
CANCER DISCOVERY (2015)
Noninvasive Saliva-based EGFR Gene Mutation Detection in Patients with Lung Cancer
Fang Wei et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease
Eli L. Diamond et al.
BLOOD (2014)
Cancer Statistics, 2014
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2014)
Double-stranded DNA in exosomes: a novel biomarker in cancer detection
Caitlin Williams et al.
CELL RESEARCH (2014)
Clinical significance of pretreatment plasma biomarkers in advanced non-small cell lung cancer patients
Shuai Wang et al.
CLINICA CHIMICA ACTA (2014)
Noninvasive Diagnosis of Actionable Mutations by Deep Sequencing of Circulating Free DNA in Lung Cancer from Never-Smokers: A Proof-of-Concept Study from BioCAST/IFCT-1002
Sebastien Couraud et al.
CLINICAL CANCER RESEARCH (2014)
Prognostic and predictive relevance of circulating tumor cells in patients with non-small-cell lung cancer
Angela Alama et al.
DRUG DISCOVERY TODAY (2014)
Identification of Double-stranded Genomic DNA Spanning All Chromosomes with Mutated KRAS and p53 DNA in the Serum Exosomes of Patients with Pancreatic Cancer
Christoph Kahlert et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Liquid Biopsies: Genotyping Circulating Tumor DNA
Luis A. Diaz et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
A Prospective, Molecular Epidemiology Study of EGFR Mutations in Asian Patients with Advanced Non-Small-Cell Lung Cancer of Adenocarcinoma Histology (PIONEER)
Yuankai Shi et al.
JOURNAL OF THORACIC ONCOLOGY (2014)
Gefitinib Treatment in EGFR Mutated Caucasian NSCLC Circulating-Free Tumor DNA as a Surrogate for Determination of EGFR Status
Jean-Yves Douillard et al.
JOURNAL OF THORACIC ONCOLOGY (2014)
Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trial
Yi-Long Wu et al.
LANCET ONCOLOGY (2014)
An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
Aaron M. Newman et al.
NATURE MEDICINE (2014)
Microfluidic, marker-free isolation of circulating tumor cells from blood samples
Nezihi Murat Karabacak et al.
NATURE PROTOCOLS (2014)
Cost-Effectiveness of CT Screening in the National Lung Screening Trial
William C. Black et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Assessment of EGFR Mutations in Circulating Tumor Cell Preparations from NSCLC Patients by Next Generation Sequencing: Toward a Real-Time Liquid Biopsy for Treatment
Antonio Marchetti et al.
PLOS ONE (2014)
Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility
Min Yu et al.
SCIENCE (2014)
Peripheral Blood for Epidermal Growth Factor Receptor Mutation Detection in Non-Small Cell Lung Cancer Patients
Xuefei Li et al.
TRANSLATIONAL ONCOLOGY (2014)
Diagnostic value of circulating free DNA for the detection of EGFR mutation status in NSCLC: a systematic review and meta-analysis
Jie Luo et al.
SCIENTIFIC REPORTS (2014)
OPINION Challenges in circulating tumour cell research
Catherine Alix-Panabieres et al.
NATURE REVIEWS CANCER (2014)
Next-Generation Sequencing Platforms
Elaine R. Mardis
ANNUAL REVIEW OF ANALYTICAL CHEMISTRY, VOL 6 (2013)
Continuous labeling of circulating tumor cells with microbeads using a vortex micromixer for highly selective isolation
Ming Xian Lin et al.
BIOSENSORS & BIOELECTRONICS (2013)
Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation
Julien Haroche et al.
BLOOD (2013)
Detection of epidermal growth factor receptor T790M mutation in plasma DNA from patients refractory to epidermal growth factor receptor tyrosine kinase inhibitor
Kazuko Sakai et al.
CANCER SCIENCE (2013)
The Clinical Utilization of Circulating Cell Free DNA (CCFDNA) in Blood of Cancer Patients
Yahya I. Elshimali et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Extracellular vesicles: Exosomes, microvesicles, and friends
Graca Raposo et al.
JOURNAL OF CELL BIOLOGY (2013)
Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations
Lecia V. Sequist et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
The diagnostic accuracy of pleural effusion and plasma samples versus tumour tissue for detection of EGFR mutation in patients with advanced non-small cell lung cancer: comparison of methodologies
Xiaoqing Liu et al.
JOURNAL OF CLINICAL PATHOLOGY (2013)
Detection of EGFR mutations in circulating free DNA by PNA-mediated PCR clamping
Hye-Ryoun Kim et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2013)
Changes in Electric Properties of Human Breast Cancer Cells
Izabela Dobrzynska et al.
JOURNAL OF MEMBRANE BIOLOGY (2013)
Can mutations of EGFR and KRAS in serum be predictive and prognostic markers in patients with advanced non-small cell lung cancer (NSCLC)?
Seung Tae Kim et al.
MEDICAL ONCOLOGY (2013)
Quantitative Identification of Mutant Alleles Derived from Lung Cancer in Plasma Cell-Free DNA via Anomaly Detection Using Deep Sequencing Data
Yoji Kukita et al.
PLOS ONE (2013)
Next-Generation Sequencing of Lung Cancer EGFR Exons 18-21 Allows Effective Molecular Diagnosis of Small Routine Samples (Cytology and Biopsy)
Dario de Biase et al.
PLOS ONE (2013)
Comparison of Epidermal Growth Factor Receptor Mutation Statuses in Tissue and Plasma in Stage I-IV Non-Small Cell Lung Cancer Patients
Xiao Zhao et al.
RESPIRATION (2013)
Circulating Tumor Cell Enrichment Based on Physical Properties
Ramdane A. Harouaka et al.
JALA (2013)
ApoStream™, a new dielectrophoretic device for antibody independent isolation and recovery of viable cancer cells from blood
Vishal Gupta et al.
BIOMICROFLUIDICS (2012)
Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition
Tobias M. Gorges et al.
BMC CANCER (2012)
EGFR-mutated oncogene-addicted non-small cell lung cancer: Current trends and future prospects
Jean-Charles Soria et al.
CANCER TREATMENT REVIEWS (2012)
Evaluation of Circulating Tumor Cells and Circulating Tumor DNA in Non-Small Cell Lung Cancer: Association with Clinical Endpoints in a Phase II Clinical Trial of Pertuzumab and Erlotinib
Elizabeth A. Punnoose et al.
CLINICAL CANCER RESEARCH (2012)
BEAMing Up Personalized Medicine: Mutation Detection in Blood
Andrea L. Richardson et al.
CLINICAL CANCER RESEARCH (2012)
First-SIGNAL: First-Line Single-Agent Iressa Versus Gemcitabine and Cisplatin Trial in Never-Smokers With Adenocarcinoma of the Lung
Ji-Youn Han et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Epidermal Growth Factor Receptor Mutation Status in Circulating Free DNA in Serum From IPASS, a Phase III Study of Gefitinib or Carboplatin/Paclitaxel in Non-small Cell Lung Cancer
Koichi Goto et al.
JOURNAL OF THORACIC ONCOLOGY (2012)
Analysis of Circulating Tumor Cells in Patients with Non-small Cell Lung Cancer Using Epithelial Marker-Dependent and -Independent Approaches
Matthew G. Krebs et al.
JOURNAL OF THORACIC ONCOLOGY (2012)
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
Rafael Rosell et al.
LANCET ONCOLOGY (2012)
The detection of EGFR mutation status in plasma is reproducible and can dynamically predict the efficacy of EGFR-TKI
Zhen Huang et al.
THORACIC CANCER (2012)
Salivary biomarker development using genomic, proteomic and metabolomic approaches
Nicolai J. Bonne et al.
GENOME MEDICINE (2012)
Resisting Targeted Therapy: Fifty Ways to Leave Your EGFR
Paul Workman et al.
CANCER CELL (2011)
Preoperative Circulating Tumor Cell Detection Using the Isolation by Size of Epithelial Tumor Cell Method for Patients with Lung Cancer Is a New Prognostic Biomarker
Veronique Hofman et al.
CLINICAL CANCER RESEARCH (2011)
Quantitative Detection of EGFR Mutations in Circulating Tumor DNA Derived from Lung Adenocarcinomas
Kazuya Taniguchi et al.
CLINICAL CANCER RESEARCH (2011)
Detection of circulating tumor cells as a prognostic factor in patients undergoing radical surgery for non-small-cell lung carcinoma: comparison of the efficacy of the CellSearch Assay™ and the isolation by size of epithelial tumor cell method
Veronique Hofman et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Serum Detection of Epidermal Growth Factor Receptor Gene Mutations Using Mutant-enriched Sequencing in Chinese Patients with Advanced Non-small Cell Lung Cancer
B. Jiang et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2011)
Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study
Caicun Zhou et al.
LANCET ONCOLOGY (2011)
Detection of EGFR mutations in plasma DNA from lung cancer patients by mass spectrometry genotyping is predictive of tumor EGFR status and response to EGFR inhibitors
Marie Brevet et al.
LUNG CANCER (2011)
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
Denise R. Aberle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Saliva: diagnostics and therapeutic perspectives
N. Spielmann et al.
ORAL DISEASES (2011)
Recurrent BRAF mutations in Langerhans cell histiocytosis
Gayane Badalian-Very et al.
BLOOD (2010)
Epidermal Growth Factor Receptor Mutations Detected by Denaturing High-Performance Liquid Chromatography in Nonsmall Cell Lung Cancer Impact on Response to Therapy With Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors
Victor Cohen et al.
CANCER (2010)
Circulating Tumor Cells: Will They Be Clinically Useful?
Nancy J. Nelson
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
APPLICATIONS OF NEXT-GENERATION SEQUENCING Sequencing technologies - the next generation
Michael L. Metzker
NATURE REVIEWS GENETICS (2010)
Isolation of circulating tumor cells using a microvortex-generating herringbone-chip
Shannon L. Stott et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Microdevice for the isolation and enumeration of cancer cells from blood
Swee Jin Tan et al.
BIOMEDICAL MICRODEVICES (2009)
Single-Molecule Detection of Epidermal Growth Factor Receptor Mutations in Plasma by Microfluidics Digital PCR in Non-Small Cell Lung Cancer Patients
Tony K. F. Yung et al.
CLINICAL CANCER RESEARCH (2009)
Noninvasive Detection of EGFR T790M in Gefitinib or Erlotinib Resistant Non-Small Cell Lung Cancer
Yanan Kuang et al.
CLINICAL CANCER RESEARCH (2009)
Detection of' epidermal growth factor receptor mutations in plasma by mutant-enriched PCR assay for prediction of the response to gefitinib in patients with non-small-celi lung cancer
Chen He et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Isolation of tumor cells using size and deformation
Hisham Mohamed et al.
JOURNAL OF CHROMATOGRAPHY A (2009)
Detection of mutated K-ras DNA in urine, plasma, and serum of patients with colorectal carcinoma or adenomatous polyps
Ying-Hsiu Su et al.
CIRCULATING NUCLEIC ACIDS IN PLASMA AND SERUM V (2008)
Detection of mutations in EGFR in circulating lung-cancer cells
Shyamala Maheswaran et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Case study of the morphologic variation of circulating tumor cells
Dena Marrinucci et al.
HUMAN PATHOLOGY (2007)
A rapid and sensitive enzymatic method for epidermal growth factor receptor mutation screening
PA Jänne et al.
CLINICAL CANCER RESEARCH (2006)
Comparison of two methods for enumerating circulating tumor cells in carcinoma patients
M Balic et al.
CYTOMETRY PART B-CLINICAL CYTOMETRY (2005)
Circulating tumor cells in breast cancer:: Correlation to bone marrow micrometastases, heterogeneous response to systemic therapy and low proliferative activity
V Müller et al.
CLINICAL CANCER RESEARCH (2005)
Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain
W Pao et al.
PLOS MEDICINE (2005)
EGFR mutation and resistance of non-small-cell lung cancer to gefitinib
S Kobayashi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
MS analysis of single-nucleotide differences in circulating nucleic acids: Application to noninvasive prenatal diagnosis
CM Ding et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Real-time genotyping with oligonucleotide probes containing locked nucleic acids
LA Ugozzoli et al.
ANALYTICAL BIOCHEMISTRY (2004)
Human urine contains small, 150 to 250 nucleotide-sized, soluble DNA derived from the circulation and may be useful in the detection of colorectal cancer
YH Su et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2004)
Transforming single DNA molecules into fluorescent magnetic particles for detection and enumeration of genetic variations
D Dressman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Comparison of two density gradient centrifugation systems for the enrichment of disseminated tumor cells in blood
R Rosenberg et al.
CYTOMETRY (2002)
Share Paper
